Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Corporate Update

11 Jul 2019 09:40

RNS Number : 2249F
Alexander Mining PLC
11 July 2019
 

11 July 2019

Alexander Mining plc

("Alexander" or the "Company")

Corporate Update

Alexander Mining plc, the AIM-listed mining, minerals and metals processing technology company, is pleased to give this corporate update.

Australia

Accudo Metals Pty Ltd ("Accudo") advises that it is currently working to deploy the licences it holds for Alexander's AmmLeach® patented technology ("Leaching Technologies") across more than one project in Australia. Accudo has a licence entitlement for up to five mining projects (each a "Project") in Australia to use its Leaching Technologies, subject to securing commercial terms with the Project owners.

 

Accudo has recently submitted indicative bids to acquire or to be the lead partner in a number of Projects.

 

The Chairman of Accudo, Dr Saliba Sassine, said it was in discussions and negotiations with asset owners or their advisors and is energetically pursuing its options to deploy the Leaching Technologies.

 

He added "We have identified several strategic opportunities ranging from projects that have substantial JORC 2012-compliant resources to established and fully permitted mines that are positioned to restart mining and having ores that are potentially amenable to the Leaching Technologies.

 

"We are in discussions and negotiations with strategic and M&A partners to structure relationships that incorporate funding packages for the Projects under evaluation and bids."

 

Deep-South Resources Inc

Under the technology licensing and consultancy agreement between Alexander Mining plc, MetaLeach Limited (collectively, "Alexander") and Deep-South Resources Inc. ("Deep-South") dated June 27, 2018, Deep-South has acquired a licence to use certain technologies owned by Alexander for the consideration of the issuance of 500,000 common shares in Deep-South (current value approximately £30,000) and a royalty of 2.5 per cent. of gross saleable metal products produced from a potential mining operation at the Kapili Tepe polymetallic project in Turkey, if using Alexander's leaching technologies.

Deep-South has issued the shares after receiving TSX Venture Exchange approval.

HyperLeach®

Testwork is currently underway on a nickel concentrate from an existing commercial operation. The aim is to leach around 50% of the contained nickel and cobalt and produce a mixed sulphide precipitate which is free from copper, arsenic and iron. The sulphide will be blended with the leach residue and sold for further processing as a low arsenic material. Analytical results from the initial proof of concept work are expected in the next few weeks. 

If successful, further developmental testwork will be proposed in partnership with the concentrate producer.

Lithium research and development

Under the joint venture with Alexander's Principal Technological Consultant, Dr. Nicholas Welham, an acknowledged expert in lithium and hydrometallurgy, the Company has been investigating and discussing potential next steps to follow up on the interesting results announced for a potential new hard rock heap leaching process for the extraction of lithium from hard zinnwaldite rocks.

Corporate

Alexander's board of directors (the "Board") is pleased that all the resolutions at the annual general meeting and the general meeting of the Company held on 28 June 2019, were duly passed. 

The Company now has the ability and flexibility to issue new shares, whether as part of an equity fund-raising or as consideration for the acquisition of new assets, as and when an opportunity may arise which may complement or enhance the Company's business.

The Board has been considering several complementary opportunities of interest in the mining sector.

The Company is pleased to report that it has either paid or has agreed waiver of payment on all amounts outstanding to current and former directors of the Company in respect of deferred payments of directors' fees identified in note 20 and included under Trade and Other Payables (note 14) of the Annual Report and Accounts for the year ending 31 December 2018. The total amount outstanding of £300,728 as at 31 December 2018 has been reduced in full to zero.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

Alexander Mining plc

Tel: +44 (0) 20 7078 9566

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

Tel: +44 (0) 20 7213 0880

 

Turner Pope Investments (TPI) Ltd.

Andy Thacker

Tel: +44 (0) 20 3657 0050

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGIGDRRXBBGCB
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.